// App-Quantinova.ai

: Impact of Inflammatory bowel disease in bronchiectasis (IBD-BR) data from the EMBARC registry

Researchers

Presenter

  • Anthony De Soyza

Principal Investigators

  • James Chalmers

  • K Dimakou

  • Adam Hill

  • Michael Loebinger

  • Rosario Menendez

  • Francesco Blasi

  • Felix Ringshausen

  • Montserrat Vendrell

  • Pietr Goeminne

  • Wim Boersma

  • Antoni Torres

  • Tobias Welte

  • Rob Wilson

  • Charles Haworth

  • Marlene Murris

  • Eva Polverino

  • Stefano Aliberti

Medical Centers

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Dundee University, Dundee, United Kingdom

  • UOA Sotiria Hospital, Athens, Greece

  • Edinburgh University, Edinburgh, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • Chest clinics, Valencia, Spain

  • University of Milan, Milan, Italy

  • Medical Clinic, Hannover, Germany

  • Gen Cat, Girona, Spain

  • AzClinics, Leuven, Belgium

  • MCA.nl, MCA.NL, Netherlands

  • Clinic Cat, Bacelona, Republic of Korea

  • Medical Clinic, Hannover, Germany

  • Papworth Hospital, Cambridge, United Kingdom

  • CHU Toulouse, Toulouse, France

  • Hospital Universitario del Mar, Barcelona, Spain

Locations

  • United Kingdom

  • Greece

  • Spain

  • Italy

  • Germany

  • Belgium

  • Netherlands

  • Republic of South Korea

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • Inflammatory bowel disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

  • Cross-Sectional

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved